Repligen Corporation cash flow to debt ratio of 17.02% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Repligen Corporation's free cash flow has decreased -34.10% from $142.49M last year to $93.90M, signaling decreasing performance

Repligen Corporation's debt to equity ratio is 0.33, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Repligen Corporation's debt has decreased relative to shareholder equity from 0.35 last year to 0.33 today, signaling strengthened financials

Repligen Corporation has a net debt to EBITDA ratio of 0.75x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Repligen Corporation earns at least as much interest as it pays. Interest obligations are fully covered.

Repligen Corporation's profit margin has increased (-267.43%) in the last year from -4.02% to 6.73%, signaling increasing performance

Repligen Corporation's short-term assets of $1.14G exceed its short-term liabilities of $135.83M

Repligen Corporation's return on assets of 1.75% is lower than the 5.00% threshold, indicating inefficient asset utilization

Repligen Corporation's return on equity of 2.46%, is lower than 15.00%, indicating bad performance

Repligen Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Repligen Corporation had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings

Repligen Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Repligen Corporation has a free cash flow yield of 1.13%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Repligen Corporation's yearly earnings has increased -291.64% since last year from $-25.51M to $48.89M, signaling increasing performance

Repligen Corporation's yearly revenue has increased 16.36% since last year from $634.44M to $738.26M, signaling increasing performance

ROIC 2.18% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Repligen Corporation's 3-year revenue CAGR of -2.70% is negative, indicating declining revenue over the past 3 years

Repligen Corporation had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance

Repligen Corporation had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity

Repligen Corporation is overvalued relative to its fair value price of 27.39 based on Discounted Cash Flow model

Repligen Corporation has an earnings yield of 0.62%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Repligen Corporation is overvalued relative to its fair value price of 18.22 based on EBITDA multiple model

Repligen Corporation has an EV/EBITDA ratio of 48.67x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Repligen Corporation is overvalued relative to its fair value price of 20.94 based on Earnings Fair Value model

Repligen Corporation has a PEG-ratio under 1 which is considered undervalued

Repligen Corporation has a price-to-book ratio of 3.93x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Repligen Corporation has a price-to-sales ratio of 10.86x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue